Logo image of ALLDL.PA

GROUPE LDLC (ALLDL.PA) Stock Fundamental Analysis

EPA:ALLDL - Euronext Paris - Matif - FR0000075442 - Common Stock - Currency: EUR

11  -0.1 (-0.9%)

Fundamental Rating

3

Overall ALLDL gets a fundamental rating of 3 out of 10. We evaluated ALLDL against 55 industry peers in the Specialty Retail industry. The financial health of ALLDL is average, but there are quite some concerns on its profitability. ALLDL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ALLDL has reported negative net income.
In the past year ALLDL has reported a negative cash flow from operations.
ALLDL had positive earnings in 4 of the past 5 years.
In the past 5 years ALLDL always reported a positive cash flow from operatings.
ALLDL.PA Yearly Net Income VS EBIT VS OCF VS FCFALLDL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a Return On Assets value of -0.07%, ALLDL perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.19%, ALLDL is in line with its industry, outperforming 43.64% of the companies in the same industry.
ALLDL has a Return On Invested Capital of 1.08%. This is in the lower half of the industry: ALLDL underperforms 60.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALLDL is in line with the industry average of 9.34%.
The 3 year average ROIC (8.16%) for ALLDL is well above the current ROIC(1.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.07%
ROE -0.19%
ROIC 1.08%
ROA(3y)4.63%
ROA(5y)6.65%
ROE(3y)10.64%
ROE(5y)17.35%
ROIC(3y)8.16%
ROIC(5y)12%
ALLDL.PA Yearly ROA, ROE, ROICALLDL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

Looking at the Operating Margin, with a value of 0.43%, ALLDL is doing worse than 63.64% of the companies in the same industry.
In the last couple of years the Operating Margin of ALLDL has declined.
Looking at the Gross Margin, with a value of 21.44%, ALLDL is doing worse than 72.73% of the companies in the same industry.
ALLDL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.43%
PM (TTM) N/A
GM 21.44%
OM growth 3Y-63.32%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.18%
GM growth 5Y14.26%
ALLDL.PA Yearly Profit, Operating, Gross MarginsALLDL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALLDL is creating some value.
ALLDL has more shares outstanding than it did 1 year ago.
ALLDL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALLDL has an improved debt to assets ratio.
ALLDL.PA Yearly Shares OutstandingALLDL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALLDL.PA Yearly Total Debt VS Total AssetsALLDL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ALLDL has an Altman-Z score of 3.04. This indicates that ALLDL is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.04, ALLDL is doing good in the industry, outperforming 76.36% of the companies in the same industry.
ALLDL has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALLDL (0.31) is better than 76.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 3.04
ROIC/WACC0.18
WACC6.02%
ALLDL.PA Yearly LT Debt VS Equity VS FCFALLDL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALLDL has a Current Ratio of 1.23. This is a normal value and indicates that ALLDL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.23, ALLDL is in line with its industry, outperforming 54.55% of the companies in the same industry.
ALLDL has a Quick Ratio of 1.23. This is a bad value and indicates that ALLDL is not financially healthy enough and could expect problems in meeting its short term obligations.
ALLDL has a Quick ratio of 0.63. This is comparable to the rest of the industry: ALLDL outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.63
ALLDL.PA Yearly Current Assets VS Current LiabilitesALLDL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ALLDL have decreased strongly by -114.14% in the last year.
ALLDL shows a small growth in Revenue. In the last year, the Revenue has grown by 0.72%.
ALLDL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.40% yearly.
EPS 1Y (TTM)-114.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.27%
Revenue 1Y (TTM)0.72%
Revenue growth 3Y-7.59%
Revenue growth 5Y2.4%
Sales Q2Q%-8.68%

3.2 Future

The Earnings Per Share is expected to grow by 61.11% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -3.32% on average over the next years.
EPS Next Y-1627.27%
EPS Next 2Y-129.62%
EPS Next 3Y61.11%
EPS Next 5YN/A
Revenue Next Year-8.88%
Revenue Next 2Y-6.27%
Revenue Next 3Y-3.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALLDL.PA Yearly Revenue VS EstimatesALLDL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
ALLDL.PA Yearly EPS VS EstimatesALLDL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALLDL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALLDL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALLDL.PA Price Earnings VS Forward Price EarningsALLDL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALLDL.PA Per share dataALLDL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as ALLDL's earnings are expected to grow with 61.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-129.62%
EPS Next 3Y61.11%

More info and screens

0

5. Dividend

5.1 Amount

ALLDL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROUPE LDLC

EPA:ALLDL (8/14/2025, 7:00:00 PM)

11

-0.1 (-0.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-31 2025-07-31
Earnings (Next)12-03 2025-12-03
Inst Owners9.82%
Inst Owner ChangeN/A
Ins Owners40.3%
Ins Owner ChangeN/A
Market Cap67.87M
Analysts37.14
Price Target6.12 (-44.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.8
Dividend Growth(5Y)13.45%
DP-2770.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 2.84
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-2.77
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS92.62
BVpS15.21
TBVpS3.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.19%
ROCE 1.86%
ROIC 1.08%
ROICexc 1.35%
ROICexgc 4.05%
OM 0.43%
PM (TTM) N/A
GM 21.44%
FCFM N/A
ROA(3y)4.63%
ROA(5y)6.65%
ROE(3y)10.64%
ROE(5y)17.35%
ROIC(3y)8.16%
ROIC(5y)12%
ROICexc(3y)11.84%
ROICexc(5y)19.2%
ROICexgc(3y)25.6%
ROICexgc(5y)73.57%
ROCE(3y)14.03%
ROCE(5y)20.67%
ROICexcg growth 3Y-76.7%
ROICexcg growth 5YN/A
ROICexc growth 3Y-70.92%
ROICexc growth 5YN/A
OM growth 3Y-63.32%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.18%
GM growth 5Y14.26%
F-Score3
Asset Turnover2.23
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.63
Altman-Z 3.04
F-Score3
WACC6.02%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.27%
EPS Next Y-1627.27%
EPS Next 2Y-129.62%
EPS Next 3Y61.11%
EPS Next 5YN/A
Revenue 1Y (TTM)0.72%
Revenue growth 3Y-7.59%
Revenue growth 5Y2.4%
Sales Q2Q%-8.68%
Revenue Next Year-8.88%
Revenue Next 2Y-6.27%
Revenue Next 3Y-3.32%
Revenue Next 5YN/A
EBIT growth 1Y-59.18%
EBIT growth 3Y-66.11%
EBIT growth 5YN/A
EBIT Next Year5%
EBIT Next 3Y21.27%
EBIT Next 5YN/A
FCF growth 1Y-167.55%
FCF growth 3Y-28.98%
FCF growth 5YN/A
OCF growth 1Y-105.32%
OCF growth 3Y-22.08%
OCF growth 5Y48.99%